
MSA Bioequivalence Centre Receives GCP and GLP Compliance Certificates from the Egyptian Drug Authority
- Date November 17, 2026
- Categories General
October University for Modern Sciences and Arts (MSA) announces that its Bioequivalence Centre has received Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) compliance certificates from the Egyptian Drug Authority (EDA). The EDA issued both certificates on 29 October 2026 following its inspection of the Centre on 5 October 2026.
The certificates confirm the Centre’s compliance with good clinical and laboratory practice standards for the activities covered by the inspection. The Centre provides pharmaceutical companies with bioequivalence and biowaiver study services, supporting the preparation of scientific documentation for medicinal product registration in line with applicable regulatory requirements.
This milestone reflects MSA University’s commitment to strengthening its research infrastructure and supporting Egypt’s pharmaceutical industry.
EDA Compliance Certificates (GCP & GLP)
You may also like
Dr. Islam ElShaarawy Wins UNDP Award in Global Open Innovation Challenge

